The Current Status of iPS Cells in Cardiac Research and Their Potential for Tissue Engineering and Regenerative Medicine

Stem Cell Reviews and Reports

Volumn 10, Issue 2, 2014, Pages 177-190

  Martins, Ana M ^a,b   Vunjak Novakovic, Gordana ^b   Reis, Rui L ^a  

^a UNIVERSITY OF MINHO   (Portugal)

^b ICVS/3B's PT Government Associate Laboratory ^*  (United States)

Author keywords

Cardiac differentiation; Cardiac disease models; Cardiac tissue engineering; Induced pluripotent stem cells; Patient specific stem cells; Pluripotency; Regenerative medicine; Reprogramming

Indexed keywords

ANIMAL; BIOLOGICAL MODEL; CELL CULTURE; CELL DIFFERENTIATION; GLYCOGEN STORAGE DISEASE; HEART DISEASES; HEART MUSCLE CELL; HUMAN; METABOLISM; PHYSIOLOGY; PLURIPOTENT STEM CELL; REGENERATIVE MEDICINE; TISSUE ENGINEERING; TRANSPLANTATION;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; GLYCOGEN STORAGE DISEASE; HEART DISEASES; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MODELS, BIOLOGICAL; MYOCYTES, CARDIAC; REGENERATIVE MEDICINE; TISSUE ENGINEERING;

EID: 84897465812     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-013-9487-7     Document Type: Review

References (185)

1. Evans, M. J., & Kaufman, M. H. (1981). Establishment in culture of pluripotential cells from mouse embryos. Nature, 292(5819), 154-156.
2. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282(5391), 1145-1147.
3. Pinto do, O. P., Kolterud, A., & Carlsson, L. (1998). Expression of the LIM-homeobox gene LH2 generates immortalized Steel factor-dependent multipotent hematopoietic precursors. EMBO Journal, 17(19), 5744-5756.
4. Shibata, N., Umesono, Y., Orii, H., Sakurai, T., Watanabe, K., & Agata, K. (1999). Expression of vasa(vas)-related genes in germline cells and totipotent somatic stem cells of planarians. Developmental Biology, 206(1), 73-87.
5. Seydoux, G., & Braun, R. E. (2006). Pathway to totipotency: Lessons from germ cells. Cell, 127(5), 891-904.
6. van de Velde, H., Cauffman, G., Tournaye, H., Devroey, P., & Liebaers, I. (2008). The four blastomeres of a 4-cell stage human embryo are able to develop individually into blastocysts with inner cell mass and trophectoderm. Human Reproduction, 23(8), 1742-1747.
7. Yoshida, Y., & Yamanaka, S. (2010). Recent stem cell advances: Induced pluripotent stem cells for disease modeling and stem cell-based regeneration. Circulation, 122(1), 80-87.
8. Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126(4), 663-676.
9. Takahashi, K., Tanabe, K., Ohnuki, M., et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131(5), 861-872.
10. Yu, J. Y., Vodyanik, M. A., Smuga-Otto, K., et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science, 318(5858), 1917-1920.
11. Robinton, D. A., & Daley, G. Q. (2012). The promise of induced pluripotent stem cells in research and therapy. Nature, 481(7381), 295-305.
12. Lowry, W. E., Richter, L., Yachechko, R., et al. (2008). Generation of human induced pluripotent stem cells from dermal fibroblasts. Proceedings of the National Academy of Sciences of the United States of America, 105(8), 2883-2888.
13. Huangfu, D. W., Osafune, K., Maehr, R., et al. (2008). Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nature Biotechnology, 26(11), 1269-1275.
14. Kim, J. B., Zaehres, H., Wu, G. M., et al. (2008). Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature, 454(7204), 646-U54.
15. Park, I. H., Zhao, R., West, J. A., et al. (2008). Reprogramming of human somatic cells to pluripotency with defined factors. Nature, 451(7175), 141-U1.
16. Loh, Y. H., Hartung, O., Li, H., et al. (2010). Reprogramming of T Cells from human peripheral blood. Cell Stem Cell, 7(1), 15-19.
17. Aoi, T., Yae, K., Nakagawa, M., et al. (2008). Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science, 321(5889), 699-702.
18. Sugii, S., Kida, Y., Kawamura, T., et al. (2010). Human and mouse adipose-derived cells support feeder-independent induction of pluripotent stem cells. Proceedings of the National Academy of Sciences of the United States of America, 107(8), 3558-3563.
19. Maherali, N., Ahfeldt, T., Rigamonti, A., Utikal, J., Cowan, C., & Hochedlinger, K. (2008). A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell, 3(3), 340-345.
20. Stadtfeld, M., Maherali, N., Breault, D. T., & Hochedlinger, K. (2008). Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell, 2(3), 230-240.
21. Yu, J. Y., Hu, K. J., Smuga-Otto, K., et al. (2009). Human induced pluripotent stem cells free of vector and transgene sequences. Science, 324(5928), 797-801.
22. Shao, L. J., Feng, W., Sun, Y., et al. (2009). Generation of iPS cells using defined factors linked via the self-cleaving 2A sequences in a single open reading frame. Cell Research, 19(3), 296-306.
23. Sommer, C. A., Stadtfeld, M., Murphy, G. J., Hochedlinger, K., Kotton, D. N., & Mostoslavsky, G. (2009). Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells, 27(3), 543-549.
24. Anokye-Danso, F., Trivedi, C. M., Juhr, D., et al. (2011). Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell, 8(4), 376-388.
25. Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G., & Hochedlinger, K. (2008). Induced pluripotent stem cells generated without viral integration. Science, 322(5903), 945-949.
26. Zhou, W. B., & Freed, C. R. (2009). Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells, 27(11), 2667-2674.
27. Okita, K., Nakagawa, M., Hong, H. J., Ichisaka, T., & Yamanaka, S. (2008). Generation of mouse induced pluripotent stem cells without viral vectors. Science, 322(5903), 949-953.
28. Si-Tayeb, K., Noto, F. K., Sepac, A., et al. (2010). Generation of human induced pluripotent stem cells by simple transient transfection of plasmid DNA encoding reprogramming factors. BMC Developmental Biology, 10.
29. Kaji, K., Norrby, K., Paca, A., Mileikovsky, M., Mohseni, P., & Woltjen, K. (2009). Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature, 458(7239), 771-U112.
30. Woltjen, K., Michael, I. P., Mohseni, P., et al. (2009). piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature, 458(7239), 766-770.
31. Belay, E., Matrai, J., Acosta-Sanchez, A., et al. (2010). Novel hyperactive transposons for genetic modification of induced pluripotent and adult stem cells: A nonviral paradigm for coaxed differentiation. Stem Cells, 28(10), 1760-1771.
32. Kim, D., Kim, C. H., Moon, J. I., et al. (2009). Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell, 4(6), 472-476.
33. Zhou, H. Y., Wu, S. L., Joo, J. Y., et al. (2009). Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell, 4(5), 381-384.
34. Warren, L., Manos, P. D., Ahfeldt, T., et al. (2010). Highly efficient reprogramming to Pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell, 7(5), 618-630.
35. Miyoshi, N., Ishii, H., Nagano, H., et al. (2011). Reprogramming of mouse and human cells to pluripotency using mature MicroRNAs. Cell Stem Cell, 8(6), 633-638.
36. Subramanyam, D., Lamouille, S., Judson, R. L., et al. (2011). Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nature Biotechnology, 29(5), 443
37. Sridharan, R., & Plath, K. (2011). Small RNAs loom large during reprogramming. Cell Stem Cell, 8(6), 599-601.
38. Fusaki, N., Ban, H., Nishiyama, A., Saeki, K., & Hasegawa, M. (2009). Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proceedings of the Japan Academy Series B-Physical and Biological Sciences, 85(8), 348-362.
39. Okita, K., Ichisaka, T., & Yamanaka, S. (2007). Generation of germline-competent induced pluripotent stem cells. Nature, 448(7151), 313-U1.
40. Xu, Y., Shi, Y., & Ding, S. (2008). A chemical approach to stem-cell biology and regenerative medicine. Nature, 453(7193), 338-344.
41. Huangfu, D. W., Maehr, R., Guo, W. J., et al. (2008). Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nature Biotechnology, 26(7), 795-797.
42. Cho, H. J., Lee, C. S., Kwon, Y. W., et al. (2010). Induction of pluripotent stem cells from adult somatic cells by protein-based reprogramming without genetic manipulation. Blood, 116(3), 386-395.
43. Shi, Y., Do, J. T., Desponts, C., Hahm, H. S., Scholer, H. R., & Ding, S. (2008). A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell, 2(6), 525-528.
44. Nakagawa, M., Koyanagi, M., Tanabe, K., et al. (2008). Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nature Biotechnology, 26(1), 101-106.
45. Wernig, M., Meissner, A., Cassady, J. P., & Jaenisch, R. (2008). c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell, 2(1), 10-12.
46. Foster, K. W., Liu, Z., Nail, C. D., et al. (2005). Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia. Oncogene, 24(9), 1491-1500.
47. Rageul, J., Mottier, S., Jarry, A., et al. (2009). KLF4-dependent, PPARgamma-induced expression of GPA33 in colon cancer cell lines. International Journal of Cancer, 125(12), 2802-2809.
48. Martinez-Fernandez, A., Nelson, T. J., Yamada, S., et al. (2009). iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism. Circulation Research, 105(7), 648-656.
49. Martinez-Fernandez, A., Nelson, T. J., Ikeda, Y., & Terzic, A. (2010). c-MYC-independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells. Journal of Cardiovascular Translational Research, 3(1), 13-23.
50. Nakagawa, M., Takizawa, N., Narita, M., Ichisaka, T., & Yamanaka, S. (2010). Promotion of direct reprogramming by transformation-deficient Myc. Proceedings of the National Academy of Sciences of the United States of America, 107(32), 14152-14157.
51. Yoshida, Y., Takahashi, K., Okita, K., Ichisaka, T., & Yamanaka, S. (2009). Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell, 5(3), 237-241.
52. Esteban, M. A., Wang, T., Qin, B. M., et al. (2010). Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell, 6(1), 71-79.
53. Kim, J. B., Sebastiano, V., Wu, G., et al. (2009). Oct4-induced pluripotency in adult neural stem cells. Cell, 136(3), 411-419.
54. Marion, R. M., Strati, K., Li, H., et al. (2009). A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature, 460(7259), 1149-U119.
55. Kawamura, T., Suzuki, J., Wang, Y. V., et al. (2009). Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature, 460(7259), 1140-U107.
56. Hong, H., Takahashi, K., Ichisaka, T., et al. (2009). Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature, 460(7259), 1132-U95.
57. Kim, S., Park, C., Han, J. W., et al. (2009). Generation of induced pluripotent stem cells from peripheral blood of coronary artery disease patients. Circulation, 120(18), S1091-S1091.
58. Kattman, S. J., Witty, A. D., Gagliardi, M., et al. (2011). Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell, 8(2), 228-240.
59. Meng, X. L., Shen, J. S., Kawagoe, S., Ohashi, T., Brady, R. O., & Eto, Y. (2010). Induced pluripotent stem cells derived from mouse models of lysosomal storage disorders. Proceedings of the National Academy of Sciences of the United States of America, 107(17), 7886-7891.
60. Niibe, K., Kawamura, Y., Araki, D., et al. (2011). Purified mesenchymal stem cells are an efficient source for iPS cell induction. Plos One, 6(3).
61. Sun, N., Panetta, N. J., Gupta, D. M., et al. (2009). Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proceedings of the National Academy of Sciences of the United States of America, 106(37), 15720-15725.
62. Cai, J., Li, W., Su, H., et al. (2010). Generation of human induced pluripotent stem cells from umbilical cord matrix and amniotic membrane mesenchymal cells. Journal of Biological Chemistry, 285(15), 11227-11234.
63. Hanna, J., Markoulaki, S., Schorderet, P., et al. (2008). Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell, 133(2), 250-264.
64. Stadtfeld, M., Brennand, K., & Hochedlinger, K. (2008). Reprogramming of pancreatic beta cells into induced pluripotent stem cells. Current Biology, 18(12), 890-894.
65. Neubauer, S. (2007). Mechanisms of disease - the failing heart - an engine out of fuel. New England Journal of Medicine, 356(11), 1140-1151.
66. Mancini, D., & Lietz, K. (2010). Selection of cardiac transplantation candidates in 2010. Circulation, 122(2), 173-183.
67. Egashira, T., Yuasa, S., & Fukuda, K. (2011). Induced pluripotent stem cells in cardiovascular medicine. Stem Cells International, 2011(348960).
68. Narazaki, G., Uosaki, H., Teranishi, M., et al. (2008). Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation, 118(5), 498-506.
69. Burridge, P. W., Keller, G., Gold, J. D., & Wu, J. C. (2012). Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell, 10(1), 16-28.
70. Mummery, C., Ward-van Oostwaard, D., Doevendans, P., et al. (2003). Differentiation of human embryonic stem cells to cardiomyocytes - role of coculture with visceral endoderm-like cells. Circulation, 107(21), 2733-2740.
71. Passier, R., Oostwaard, D. W. V., Snapper, J., et al. (2005). Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures. Stem Cells, 23(6), 772-780.
72. Freund, C., Oostwaard, D. W. V., Monshouwer-Kloots, J., et al. (2008). Insulin redirects differentiation from cardiogenic mesoderm and endoderm to neuroectoderm in differentiating human embryonic stem cells. Stem Cells, 26(3), 724-733.
73. Lahti, A. L., Kujala, V. J., Chapman, H., et al. (2012). Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture. Disease Models & Mechanisms, 5(2), 220-230.
74. Denning, C., Allegrucci, C., Priddle, H., et al. (2006). Common culture conditions for maintenance and cardiomyocyte differentiation of the human embryonic stem cell lines, BG01 and HUES-7. International Journal of Developmental Biology, 50(1), 27-37.
75. Burridge, P. W., Anderson, D., Priddle, H., et al. (2007). Improved human embryonic stem cell embryoid body homogeneity and cardiomyocyte differentiation from a novel V-96 plate aggregation system highlights interline variability. Stem Cells, 25(4), 929-938.
76. Zhang, J. H., Wilson, G. F., Soerens, A. G., et al. (2009). Functional cardiomyocytes derived from human induced pluripotent stem cells. Circulation Research, 104(4), E30-E41.
77. Narsinh, K., Narsinh, K. H., & Wu, J. C. (2011). Derivation of human induced pluripotent stem cells for cardiovascular disease modeling. Circulation Research, 108(9), 1146-1156.
78. Burridge, P. W., Thompson, S., Millrod, M. A., et al. (2011). A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. Plos One, 6(4).
79. Egashira, T., Yuasa, S., Suzuki, T., et al. (2012). Disease characterization using LQTS-specific induced pluripotent stem cells. Cardiovascular Research, 95(4), 419-429.
80. Bellin, M., Marchetto, M. C., Gage, F. H., & Mummery, C. L. (2012). Induced pluripotent stem cells: the new patient? Nature Reviews Molecular Cell Biology, 13(11), 713-726.
81. Laflamme, M. A., Chen, K. Y., Naumova, A. V., et al. (2007). Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nature Biotechnology, 25(9), 1015-1024.
82. Ojala, M., Rajala, K., Pekkanen-Mattila, M., Miettinen, M., Huhtala, H., & Aalto-Setala, K. (2012). Culture conditions affect cardiac differentiation potential of human pluripotent stem cells. Plos One, 7(10).
83. Davis, R. P., Casini, S., van den Berg, C. W., et al. (2012). Cardiomyocytes derived from pluripotent stem cells recapitulate electrophysiological characteristics of an overlap syndrome of cardiac sodium channel disease. Circulation, 125(25), 3079
84. Moretti, A., Bellin, M., Welling, A., et al. (2010). Patient-specific induced pluripotent stem-cell models for long-QT syndrome. New England Journal of Medicine, 363(15), 1397-1409.
85. Ge, X., Ren, Y. M., Bartulos, O., et al. (2012). Modeling supravalvular aortic stenosis syndrome with human induced pluripotent stem cells. Circulation, 126(14), 1695
86. Sun, N., Yazawa, M., Liu, J. W., et al. (2012). Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Science Translational Medicine, 4(130).
87. Ma, D., Wei, H., Lu, J., et al. (2013) Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy. Eur Heart J.
88. Kehat, I., Kenyagin-Karsenti, D., Snir, M., et al. (2001). Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. Journal of Clinical Investigation, 108(3), 407-414.
89. Gepstein, L. (2002). Derivation and potential applications of human embryonic stem cells. Circulation Research, 91(10), 866-876.
90. Xu, C. H., Police, S., Rao, N., & Carpenter, M. K. (2002). Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circulation Research, 91(6), 501-508.
91. Yang, L., Soonpaa, M. H., Adler, E. D., et al. (2008). Human cardiovascular progenitor cells develop from a KDR plus embryonic-stem-cell-derived population. Nature, 453(7194), 524-U6.
92. Xu, H. S., Yi, B. A., Wu, H., et al. (2012). Highly efficient derivation of ventricular cardiomyocytes from induced pluripotent stem cells with a distinct epigenetic signature. Cell Research, 22(1), 142-154.
93. Zwi-Dantsis, L., Huber, I., Habib, M., et al. (2013). Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients. European Heart Journal, 34(21), 1575-1586.
94. Ng, E. S., Davis, R., Stanley, E. G., & Elefanty, A. G. (2008). A protocol describing the use of a recombinant protein-based, animal product-free medium (APEL) for human embryonic stem cell differentiation as spin embryoid bodies. Nature Protocols, 3(5), 768-776.
95. Xu, X. Q., Graichen, R., Soo, S. Y., et al. (2008). Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cells. Differentiation, 76(9), 958-970.
96. Uosaki, H., Fukushima, H., Takeuchi, A., et al. (2011). Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression. Plos One, 6(8).
97. Ban, K., Wile, B., Kim, S., et al. (2013). Purification of cardiomyocytes from differentiating pluripotent stem cells using molecular beacons that target cardiomyocyte-specific mRNA. Circulation, 128(17), 1897-1909.
98. Hattori, F., Chen, H., Yamashita, H., et al. (2010). Nongenetic method for purifying stem cell-derived cardiomyocytes. Nature Methods, 7(1), 61-U15.
99. Mauritz, C., Schwanke, K., Reppel, M., et al. (2008). Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation, 118(5), 507-517.
100. Zhang, J. H., Soerens, A. G., Wilson, G. F., Yu, J. Y., Thomson, J. A., & Kamp, T. J. (2009). Human induced pluripotent stem cells free of vector and transgene sequences undergo cardiogenesis in defined conditions. Circulation, 120(18), S1123-S1124.
101. Germanguz, I., Sedan, O., Zeevi-Levin, N., et al. (2011). Molecular characterization and functional properties of cardiomyocytes derived from human inducible pluripotent stem cells. Journal of Cellular and Molecular Medicine, 15(1), 38-51.
102. van Laake, L. W., Qian, L., Cheng, P., et al. (2010). Reporter-based isolation of induced pluripotent stem cell- and embryonic stem cell-derived cardiac progenitors reveals limited gene expression variance. Circulation Research, 107(3), 340-347.
103. Xi, J. Y., Khalil, M., Shishechian, N., et al. (2010). Comparison of contractile behavior of native murine ventricular tissue and cardiomyocytes derived from embryonic or induced pluripotent stem cells. Faseb Journal, 24(8), 2739-2751.
104. Naito, A. T., Shiojima, I., Akazawa, H., Kikuchi, A., & Komuro, I. (2006). Developmental stage-specific roles of Wnt/ss-catenin signaling in cardiomyogenesis. Circulation, 114(18), 233-233.
105. Ueno, S., Weidinger, G., Osugi, T., et al. (2007). Biphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 104(23), 9685-9690.
106. Klaus, A., Saga, Y., Taketo, M. M., Tzahor, E., & Birchmeier, W. (2007). Distinct roles of Wnt/beta-catenin and Bmp signaling during early cardiogenesis. Proceedings of the National Academy of Sciences of the United States of America, 104(47), 18531-18536.
107. Paige, S. L., Osugi, T., Afanasiev, O. K., Pabon, L., Reinecke, H., & Murry, C. E. (2010). Endogenous Wnt/beta-catenin signaling is required for cardiac differentiation in human embryonic stem cells. Plos One, 5(6).
108. Sa, S., & McCloskey, K. E. (2012). Stage-specific cardiomyocyte differentiation method for H7 and H9 human embryonic stem cells. Stem Cell Reviews and Reports, 8(4), 1120-1128.
109. Yuasa, S., Itabashi, Y., Koshimizu, U., et al. (2005). Transient inhibition of BMP signaling by Noggin induces cardiomyocyte differentiation of mouse embryonic stem cells. Nature Biotechnology, 23(7), 897-897.
110. Cao, N., Liu, Z. M., Chen, Z. Y., et al. (2012). Ascorbic acid enhances the cardiac differentiation of induced pluripotent stem cells through promoting the proliferation of cardiac progenitor cells. Cell Research, 22(1), 219-236.
111. Fujiwara, M., Yan, P. S., Otsuji, T. G., et al. (2011). Induction and enhancement of cardiac cell differentiation from mouse and human induced pluripotent stem cells with cyclosporin-a. Plos One, 6(2).
112. Polo, J. M., Liu, S., Figueroa, M. E., et al. (2010). Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nature Biotechnology, 28(8), 848-U130.
113. Kim, K., Doi, A., Wen, B., et al. (2010). Epigenetic memory in induced pluripotent stem cells. Nature, 467(7313), 285-U60.
114. Hu, Q. R., Friedrich, A. M., Johnson, L. V., & Clegg, D. O. (2010). Memory in induced pluripotent stem cells: reprogrammed human retinal-pigmented epithelial cells show tendency for spontaneous redifferentiation. Stem Cells, 28(11), 1981-1991.
115. Osafune, K., Caron, L., Borowiak, M., et al. (2008). Marked differences in differentiation propensity among human embryonic stem cell lines. Nature Biotechnology, 26(3), 313-315.
116. Beqqali, A., Kloots, J., Ward-van Oostwaard, D., Mummery, C., & Passier, R. (2006). Genome-wide transcriptional profiling of human embryonic stem cells differentiating to cardiomyocytes. Stem Cells, 24(8), 1956-1967.
117. Davis, R. P., van den Berg, C. W., Casini, S., Braam, S. R., & Mummery, C. L. (2011). Pluripotent stem cell models of cardiac disease and their implication for drug discovery and development. Trends in Molecular Medicine, 17(9), 475-484.
118. Rosenzweig, A. (2010). Illuminating the potential of pluripotent stem cells. New England Journal of Medicine, 363(15), 1471-1472.
119. Belmonte, J. C., Ellis, J., Hochedlinger, K., & Yamanaka, S. (2009). Induced pluripotent stem cells and reprogramming: seeing the science through the hype. Nature Reviews Genetics, 10(12), 878-883.
120. Rolletschek, A., & Wobus, A. M. (2009). Induced human pluripotent stem cells: promises and open questions. Biological Chemistry, 390(9), 845-849.
121. Pei, D. Q., Xu, J. Y., Zhuang, Q. A., Tse, H. F., & Esteban, M. A. (2010). Induced pluripotent stem cell technology in regenerative medicine and biology. Bioreactor Systems for Tissue Engineering Ii: Strategies for the Expanison and Directed Differentiation of Stem Cells, 123(127-141).
122. Carvajal-Vergara, X., Sevilla, A., D'Souza, S. L., et al. (2010). Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature, 465(7299), 808-U12.
123. Lin, B., Kim, J., Li, Y. X., et al. (2012). High-purity enrichment of functional cardiovascular cells from human iPS cells. Cardiovascular Research, 95(3), 327-335.
124. Itzhaki, I., Maizels, L., Huber, I., et al. (2011). Modelling the long QT syndrome with induced pluripotent stem cells. Nature, 471(7337), 225-U113.
125. Matsa, E., Rajamohan, D., Dick, E., et al. (2011). Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation. European Heart Journal, 32(8), 952-962.
126. Dirschinger, R. J., Goedel, A., Moretti, A., Laugwitz, K. L., & Sinnecker, D. (2012). Recapitulating long-QT syndrome using induced pluripotent stem cell technology. Pediatric Cardiology, 33(6), 950-958.
127. Yazawa, M., Hsueh, B., Jia, X. L., et al. (2011). Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature, 471(7337), 230-U120.
128. Yazawa, M., & Dolmetsch, R. E. (2013). Modeling Timothy syndrome with iPS cells. Journal of Cardiovascular Translational Research, 6(1), 1-9.
129. Fatima, A., Xu, G. X., Shao, K. F., et al. (2011). In vitro modeling of Ryanodine receptor 2 dysfunction using human induced pluripotent stem cells. Cellular Physiology and Biochemistry, 28(4), 579-592.
130. Jung, C. B., Moretti, A., Schnitzler, M. M. Y., et al. (2012). Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia. EMBO Molecular Medicine, 4(3), 180-191.
131. Liu, J., Verma, P. J., Evans-Galea, M. V., et al. (2011). Generation of induced pluripotent stem cell lines from Friedreich Ataxia patients. Stem Cell Reviews and Reports, 7(3), 703-713.
132. Du, J. T., Campau, E., Soragni, E., et al. (2012). Role of mismatch repair enzymes in GAA. TTC triplet-repeat expansion in Friedreich Ataxia induced pluripotent stem cells. Journal of Biological Chemistry, 287(35), 29861-29872.
133. Huang, H. P., Chen, P. H., Hwu, W. L., et al. (2011). Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification. Human Molecular Genetics, 20(24), 4851-4864.
134. Huang, H. P., Chuang, C. Y., & Kuo, H. C. (2012). Induced pluripotent stem cell technology for disease modeling and drug screening with emphasis on lysosomal storage diseases. Stem Cell Research & Therapy, 3.
135. Clegg, S., Gong, Q., Zhou, Z. and Adler, E (2011) A novel in vitro model of Danon disease confirms the critical role of LAMP2 in regulating autophagy. In AHA/ASA.
136. Kamp, T. J., & Lyons, G. E. (2009). On the road to iPS cell cardiovascular applications. Circulation Research, 105(7), 617-619.
137. Saha, K., & Jaenisch, R. (2009). Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell, 5(6), 584-595.
138. Yoshida, Y., & Yamanaka, S. (2011). iPS cells: A source of cardiac regeneration. Journal of Molecular and Cellular Cardiology, 50(2), 327-332.
139. Park, I. H., Arora, N., Huo, H., et al. (2008). Disease-specific induced pluripotent stem cells. Cell, 134(5), 877-886.
140. Sarkozy, A., Digilio, M. C., & Dallapiccola, B. (2008). Leopard syndrome. Orphanet Journal of Rare Diseases, 3(13).
141. Marban, E. (2002). Cardiac channelopathies. Nature, 415(6868), 213-218.
142. Sanguinetti, M. C., & Tristani-Firouzi, M. (2006). hERG potassium channels and cardiac arrhythmia. Nature, 440(7083), 463-469.
143. Goldenberg, I., & Moss, A. J. (2008). Long QT syndrome. Journal of the American College of Cardiology, 51(24), 2291-2300.
144. Wilde, A. A. M., & Bezzina, C. R. (2005). Genetics of cardiac arrhythmias. Heart, 91(10), 1352-1358.
145. Splawski, I., Timothy, K. W., Sharpe, L. M., et al. (2004). Ca(v)1. 2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell, 119(1), 19-31.
146. Priori, S. G., Napolitano, C., Memmi, M., et al. (2002). Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation, 106(1), 69-74.
147. Scheinman, M. M., & Lam, J. (2006). Exercise-induced ventricular arrhythmias in patients with no structural cardiac disease. Annual Review of Medicine, 57(473-484).
148. Basso, C., Corrado, D., Marcus, F. I., Nava, A., & Thiene, G. (2009). Arrhythmogenic right ventricular cardiomyopathy. Lancet, 373(9671), 1289-1300.
149. Arad, M., Maron, B. J., Gorham, J. M., et al. (2005). Glycogen storage diseases presenting as hypertrophic cardiomyopathy. New England Journal of Medicine, 352(4), 362-372.
150. Vunjak-Novakovic, G. (2008). Patterning stem cell differentiation. Cell Stem Cell, 3(4), 362-363.
151. Stamm, C., Klose, K., & Choi, Y. H. (2010). Clinical application of stem cells in the cardiovascular system. Bioreactor Systems for Tissue Engineering Ii: Strategies for the Expanison and Directed Differentiation of Stem Cells, 123(293-317).
152. Soonpaa, M. H., Koh, G. Y., Klug, M. G., & Field, L. J. (1994). Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science, 264(5155), 98-101.
153. Orlic, D., Kajstura, J., Chimenti, S., et al. (2001). Bone marrow cells regenerate infarcted myocardium. Nature, 410(6829), 701-705.
154. Zhang, M., Methot, D., Poppa, V., Fujio, Y., Walsh, K., & Murry, C. E. (2001). Cardiomyocyte grafting for cardiac repair: Graft cell death and anti-death strategies. Journal of Molecular and Cellular Cardiology, 33(5), 907-921.
155. Dow, J., Simkhovich, B. Z., Kedes, L., & Kloner, R. A. (2005). Washout of transplanted cells from the heart: A potential new hurdle for cell transplantation therapy. Cardiovascular Research, 67(2), 301-307.
156. Qiao, H., Surti, S., Choi, S. R., et al. (2009). Death and proliferation time course of stem cells transplanted in the myocardium. Molecular Imaging and Biology, 11(6), 408-414.
157. Hofmann, M., Wollert, K. C., Meyer, G. P., et al. (2005). Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation, 111(17), 2198-2202.
158. Vunjak-Novakovic, G., Tandon, N., Godier, A., et al. (2010). Challenges in cardiac tissue engineering. Tissue Engineering. Part B, Reviews, 16(2), 169-187.
159. Jawad, H., Ali, N. N., Lyon, A. R., Chen, Q. Z., Harding, S. E., & Boccaccini, A. R. (2007). Myocardial tissue engineering: a review. Journal of Tissue Engineering and Regenerative Medicine, 1(5), 327-342.
160. Zimmermann, W. H. (2008). Tissue engineering polymers flex their muscles. Nature Materials, 7(12), 932-933.
161. Rosellini, E., Cristallini, C., Barbani, N., Vozzi, G., & Giusti, P. (2009). Preparation and characterization of alginate/gelatin blend films for cardiac tissue engineering. Journal of Biomedical Materials Research, Part A, 91A(2), 447-453.
162. Zhang, T., Wan, L. Q., Xiong, Z., et al. (2012). Channelled scaffolds for engineering myocardium with mechanical stimulation. Journal of Tissue Engineering and Regenerative Medicine, 6(9), 748-756.
163. Chimenti, I., Rizzitelli, G., Gaetani, R., et al. (2011). Human cardiosphere-seeded gelatin and collagen scaffolds as cardiogenic engineered bioconstructs. Biomaterials, 32(35), 9271-9281.
164. Tandon, N., Marsano, A., Maidhof, R., Wan, L., Park, H., & Vunjak-Novakovic, G. (2011). Optimization of electrical stimulation parameters for cardiac tissue engineering. Journal of Tissue Engineering and Regenerative Medicine, 5(6), E115-E125.
165. Chi, N. H., Yang, M. C., Chung, T. W., Chen, J. Y., Chou, N. K., & Wang, S. S. (2012). Cardiac repair achieved by bone marrow mesenchymal stem cells/silk fibroin/hyaluronic acid patches in a rat of myocardial infarction model. Biomaterials, 33(22), 5541-5551.
166. Patra, C., Talukdar, S., Novoyatleva, T., et al. (2012). Silk protein fibroin from Antheraea mylitta for cardiac tissue engineering. Biomaterials, 33(9), 2673-2680.
167. Godier-Furnemont, A. F. G., Martens, T. P., Koeckert, M. S., et al. (2011). Composite scaffold provides a cell delivery platform for cardiovascular repair. Proceedings of the National Academy of Sciences of the United States of America, 108(19), 7974-7979.
168. Marsano, A., Maidhof, R., Luo, J. W., et al. (2013). The effect of controlled expression of VEGF by transduced myoblasts in a cardiac patch on vascularization in a mouse model of myocardial infarction. Biomaterials, 34(2), 393-401.
169. Kuo, Y. C., & Huang, M. J. (2012). Material-driven differentiation of induced pluripotent stem cells in neuron growth factor-grafted poly(epsilon-caprolactone)-poly(beta-hydroxybutyrate) scaffolds. Biomaterials, 33(23), 5672-5682.
170. Wen, Y., Wang, F., Zhang, W. C., et al. (2012). Application of induced pluripotent stem cells in generation of a tissue-engineered tooth-like structure. Tissue Engineering Part A, 18(15-16), 1677-1685.
171. Miki, K., Uenaka, H., Saito, A., et al. (2012). Bioengineered myocardium derived from induced pluripotent stem cells improves cardiac function and attenuates cardiac remodeling following chronic myocardial infarction in rats. Stem Cells Translational Medicine, 1(5), 430-437.
172. Nelson, T. J., Martinez-Fernandez, A., Yamada, S., Perez-Terzic, C., Ikeda, Y., & Terzic, A. (2009). Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation, 120(5), 408-416.
173. Mauritz, C., Martens, A., Rojas, S. V., et al. (2011). Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction. European Heart Journal, 32(21), 2634-2641.
174. Okano, T., Yamada, N., Okuhara, M., Sakai, H., & Sakurai, Y. (1995). Mechanism of cell detachment from temperature-modulated, hydrophilic-hydrophobic polymer surfaces. Biomaterials, 16(4), 297-303.
175. Miki, K., Saito, A., Uenaka, H., et al. (2009). Cardiomyocyte sheets derived from induced pluripotent stem (iPS) cells improve cardiac function and attenuate cardiac remodeling in myocardial infarction in mice. Circulation, 120(18), S721-S721.
176. Haraguchi, Y., Matsuura, K., Shimizu, T., Yamato, M., & Okano, T. (2012). Expansion and cardiac differentiation of human iPS cells using a suspension culture system. Journal of Tissue Engineering and Regenerative Medicine, 6(252-252).
177. Matsuura, K. M., Shimizu, T. S., Wada, M. W., et al. (2012). Creation of cell sheet-based bioengineered heart tissue using ES/iPS cells-derived cells. Journal of Tissue Engineering and Regenerative Medicine, 6(103-103).
178. Sawa, Y., Miyagawa, S., Sakaguchi, T., et al. (2012). Tissue engineered myoblast sheets improved cardiac function sufficiently to discontinue LVAS in a patient with DCM: report of a case. Surgery Today, 42(2), 181-184.
179. Hibino, N., Duncan, D. R., Nalbandian, A., et al. (2012). Evaluation of the use of an induced puripotent stem cell sheet for the construction of tissue-engineered vascular grafts. Journal of Thoracic and Cardiovascular Surgery, 143(3), 696-703.
180. Tulloch, N. L., Muskheli, V., Razumova, M. V., et al. (2011). Growth of engineered human myocardium with mechanical loading and vascular coculture. Circulation Research, 109(1), 47-U195.
181. Eschenhagen, T., Fink, C., Remmers, U., et al. (1997). Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. Faseb Journal, 11(8), 683-694.
182. Zimmermann, W. H., Fink, C., Kralisch, D., Remmers, U., Weil, J., & Eschenhagen, T. (2000). Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnology and Bioengineering, 68(1), 106-114.
183. Eschenhagen, T. (2011). The beat goes on: human heart muscle from pluripotent stem cells. Circulation Research, 109(1), 1-3.
184. Miura, K., Okada, Y., Aoi, T., et al. (2009). Variation in the safety of induced pluripotent stem cell lines. Nature Biotechnology, 27(8), 743-745.
185. Yamanaka, S. (2010). Patient-specific pluripotent stem cells become even more accessible. Cell Stem Cell, 7(1), 1-2.